MALLEO, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 15.940
NA - Nord America 15.931
AS - Asia 11.247
SA - Sud America 1.674
AF - Africa 390
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 45.230
Nazione #
US - Stati Uniti d'America 15.516
RU - Federazione Russa 6.169
SG - Singapore 4.409
CN - Cina 3.192
GB - Regno Unito 2.600
IT - Italia 2.375
BR - Brasile 1.320
VN - Vietnam 994
HK - Hong Kong 987
DE - Germania 951
FR - Francia 909
IE - Irlanda 761
SE - Svezia 755
FI - Finlandia 433
KR - Corea 324
BD - Bangladesh 314
IN - India 222
CA - Canada 220
NL - Olanda 214
JP - Giappone 175
UA - Ucraina 155
MX - Messico 135
AR - Argentina 129
ES - Italia 119
TR - Turchia 101
NG - Nigeria 92
PL - Polonia 90
ID - Indonesia 88
IQ - Iraq 80
ZA - Sudafrica 71
AT - Austria 70
BE - Belgio 57
PK - Pakistan 56
EC - Ecuador 45
CZ - Repubblica Ceca 43
VE - Venezuela 38
CO - Colombia 37
TG - Togo 37
MA - Marocco 35
LT - Lituania 34
AU - Australia 33
BJ - Benin 31
CL - Cile 30
PH - Filippine 29
PY - Paraguay 29
TN - Tunisia 29
UZ - Uzbekistan 29
CH - Svizzera 28
NP - Nepal 26
EG - Egitto 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
PE - Perù 23
SA - Arabia Saudita 23
RO - Romania 22
KE - Kenya 20
DZ - Algeria 18
AZ - Azerbaigian 17
GR - Grecia 17
IL - Israele 15
MY - Malesia 15
LV - Lettonia 14
HU - Ungheria 13
PT - Portogallo 13
KG - Kirghizistan 12
TH - Thailandia 12
AL - Albania 11
NO - Norvegia 11
DK - Danimarca 10
IR - Iran 10
JM - Giamaica 10
KZ - Kazakistan 10
SI - Slovenia 10
CR - Costa Rica 9
HR - Croazia 9
RS - Serbia 9
UY - Uruguay 9
BG - Bulgaria 8
BO - Bolivia 8
ET - Etiopia 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
OM - Oman 7
LB - Libano 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
BA - Bosnia-Erzegovina 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BH - Bahrain 4
EE - Estonia 4
GA - Gabon 4
GT - Guatemala 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
UG - Uganda 4
Totale 45.155
Città #
Singapore 2.299
Moscow 2.174
Southend 2.152
Ashburn 1.999
Dallas 1.809
San Jose 1.562
Chandler 1.499
Hong Kong 966
Verona 809
Dublin 736
Beijing 574
The Dalles 509
Jacksonville 508
Council Bluffs 494
Woodbridge 493
New York 423
Houston 369
Ho Chi Minh City 344
Los Angeles 314
Ann Arbor 306
Munich 293
Lawrence 243
Princeton 243
Hanoi 215
Jinan 215
Wilmington 215
Nanjing 178
Helsinki 175
Shenyang 157
São Paulo 155
Boardman 142
Tokyo 142
Redondo Beach 141
Santa Clara 141
Buffalo 140
Orem 136
Milan 130
Hebei 118
Redmond 111
Columbus 97
Sindelfingen 96
Tianjin 94
Turku 94
London 93
Abuja 83
Montreal 82
Seattle 82
Frankfurt am Main 81
Haikou 79
Rome 77
Hangzhou 73
Chennai 71
Zhengzhou 69
Ningbo 68
Warsaw 68
Changsha 67
Amsterdam 65
Denver 65
San Francisco 65
Bologna 64
Stockholm 61
Toronto 61
Atlanta 60
Chicago 57
Guangzhou 57
Brooklyn 55
Phoenix 55
Fairfield 54
Nanchang 53
Poplar 53
Brussels 52
Da Nang 50
Mexico City 50
Taizhou 49
Falkenstein 48
Redwood City 48
Johannesburg 47
Lancaster 47
Seoul 47
Haiphong 45
Rio de Janeiro 45
Taiyuan 45
Jiaxing 44
Nuremberg 42
Mumbai 38
Washington 38
Baghdad 37
Lomé 37
Paris 37
Vienna 37
Belo Horizonte 36
Lappeenranta 34
Jakarta 33
Manchester 33
Cotonou 31
Istanbul 28
Norwalk 27
Brasília 26
Fuzhou 26
Kent 26
Totale 27.011
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 952
STUDIO PROSPETTICO MULTICENTRICO SULLA GESTIONE DEI DRENAGGI DOPO DUODENOCEFALOPANCREASECTOMIA UTILIZZANDO UN SISTEMA DI STRATIFICAZIONE DEL RISCHIO 712
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 291
Genomic characterization of hepatoid tumors: context matters 261
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 253
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 253
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 252
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 250
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 248
Gα15 in early onset of pancreatic ductal adenocarcinoma 239
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 237
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 231
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 226
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 220
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 219
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 219
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 219
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 216
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 216
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 215
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 213
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 212
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 210
Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases 208
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 207
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 207
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 206
Acute pancreatitis at the beginning of the 21st century: the state of the art. 206
Delaying surgery for patients with a previous SARS-CoV-2 infection 204
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 203
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 203
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 199
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 197
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 197
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 195
Sex differences in oncogenic mutational processes 195
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 194
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 193
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 192
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
Efficacy of Endoscopic Minor Papilla Sphincterotomy for Symptomatic Santorinicele Endoscopic treatment of Santorinicele 190
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 187
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 185
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 185
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 184
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 184
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 183
An unforeseeable adverse event during ERCP 182
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 180
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 179
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 179
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 178
Serous Cystic Neoplasms 177
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 177
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 177
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 177
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 176
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 175
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 175
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 175
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 175
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 174
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 174
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 174
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 174
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 173
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 173
Immune performance profile in pancreatic adenocarcinoma patients. 172
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 172
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 170
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 169
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or~Tail on Surgical and Oncological Outcome: A Propensity-Score~Matched Multicenter Study 169
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 169
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 167
The management of intraductal papillary mucinous neoplasms of the pancreas 167
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 166
Cystic Neoplasm of the Pancreas 166
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 165
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 165
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 164
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 164
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study 164
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 164
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 163
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons 163
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 163
A Surface Plasmon Resonance Plastic Optical Fiber Biosensor for the Detection of Pancreatic Amylase in Surgically-Placed Drain Effluent 163
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 163
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 162
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula 162
Totale 20.745
Categoria #
all - tutte 154.179
article - articoli 145.114
book - libri 0
conference - conferenze 2.444
curatela - curatele 0
other - altro 2.258
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.363
Totale 308.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 0 104
2021/20221.828 184 448 51 139 59 34 33 127 98 51 139 465
2022/20234.811 291 521 401 765 398 1.324 114 307 473 53 97 67
2023/20242.660 88 217 261 277 281 417 169 221 47 102 429 151
2024/20256.738 356 335 248 1.027 359 203 420 345 996 497 664 1.288
2025/202622.523 1.417 1.390 1.636 3.575 5.367 1.410 1.880 1.330 1.927 1.322 517 752
Totale 45.730